Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Dividends Paid - Common (2016 - 2025)

Bio-Techne has reported Dividends Paid - Common over the past 17 years, most recently at $12.5 million for Q4 2025.

  • Quarterly results put Dividends Paid - Common at $12.5 million for Q4 2025, down 2.09% from a year ago — trailing twelve months through Dec 2025 was $49.9 million (down 1.48% YoY), and the annual figure for FY2025 was $50.4 million, changed 0.06%.
  • Dividends Paid - Common for Q4 2025 was $12.5 million at Bio-Techne, roughly flat from $12.4 million in the prior quarter.
  • Over the last five years, Dividends Paid - Common for TECH hit a ceiling of $12.7 million in Q4 2024 and a floor of $12.4 million in Q2 2025.
  • Median Dividends Paid - Common over the past 5 years was $12.6 million (2021), compared with a mean of $12.6 million.
  • Biggest five-year swings in Dividends Paid - Common: increased 1.55% in 2021 and later fell 2.09% in 2025.
  • Bio-Techne's Dividends Paid - Common stood at $12.6 million in 2021, then dropped by 0.12% to $12.6 million in 2022, then fell by 0.02% to $12.6 million in 2023, then increased by 1.41% to $12.7 million in 2024, then fell by 2.09% to $12.5 million in 2025.
  • The last three reported values for Dividends Paid - Common were $12.5 million (Q4 2025), $12.4 million (Q3 2025), and $12.4 million (Q2 2025) per Business Quant data.